Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation

Published:2018-01 Issue:1 Volume:102 Page:97-104
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Yamamoto Hidekazu,Uchida Koshi,Kawabata Seiichi,Isono Kaori,Miura Kohei,Hayashida Shintaro,Oya Yuki,Sugawara Yasuhiko,Inomata Yukihiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference35 articles.

1. Liver transplantation across ABO blood group barriers;Gugenheim;Lancet,1990

2. Living donor liver transplantation in adults: outcome in Japan;Todo;Liver Transpl,2000

3. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients;Farges;Transplantation,1995

4. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of rituximab, hepatic arterial infusion, and preservation of spleen;Yoshizawa;Transplant Proc,2005

5. Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era;Ikegami;Liver Transpl,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apheresis Indications in the Perioperative Setting;Current Anesthesiology Reports;2024-06-15

2. Immunology demystified: A guide for transplant hepatologists;World Journal of Transplantation;2024-03-18

3. Living donor liver transplantation for Wilson disease: A collective review;Annals of Liver Transplantation;2023-11-27

4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

5. Strategies for ABO Incompatible Liver Transplantation;Journal of Clinical and Experimental Hepatology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3